|
Market Closed -
London S.E.
18:35:02 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.1550 GBX | 0.00% |
|
0.00% | -53.73% |
| 08-10 | ValiRx subsidiary Cytolytix nears "significant" European patent win | AN |
| 08-10 | ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +3.33% | -20.51% | -53.73% | -76.15% | -97.48% | -99.25% | -99.99% | 2.77M | |
| -1.59% | -3.35% | +25.44% | +54.92% | +73.65% | +52.37% | +91.62% | +20.66% | - | 69.54B | |
| -1.34% | -0.75% | +19.90% | +25.10% | +24.89% | +48.21% | +92.23% | +212.03% | +6,434.31% | 64.97B | |
| -4.24% | -0.12% | +25.30% | +40.21% | +54.39% | +34.91% | +9.94% | -59.68% | - | 26.51B | |
| -2.35% | -5.75% | +16.80% | +10.88% | -31.89% | -12.90% | +436.87% | +328.72% | +793.29% | 25.89B | |
| -8.37% | -12.43% | +9.94% | +6.38% | +7.22% | +2.08% | -18.39% | -70.41% | - | 25.64B | |
| -0.96% | +10.36% | +50.73% | +84.28% | +264.65% | +283.06% | +429.04% | +1,992.29% | +1,074.01% | 20.22B | |
| -0.51% | +0.23% | +16.92% | +26.53% | +6.36% | +35.77% | -19.61% | -28.56% | +96.89% | 19.98B | |
| -4.06% | -5.47% | +2.19% | +13.55% | +26.06% | +1.73% | +546.27% | - | - | 15.69B | |
| -1.47% | +0.68% | -2.72% | +7.86% | +24.23% | +45.51% | +142.00% | +182.71% | +393.21% | 13.49B | |
| -1.83% | +3.29% | +8.24% | +7.34% | -8.34% | +21.90% | +199.71% | +542.54% | +4,796.88% | 12.33B | |
| -4.15% | -2.53% | -2.76% | +8.98% | +27.90% | +285.43% | +216.36% | +27.03% | +1,099.29% | 11.99B | |
| -4.88% | +2.66% | -3.46% | -21.74% | -19.73% | -42.59% | +163.28% | +125.62% | - | 11.2B | |
| -4.19% | +4.33% | +2.16% | -21.72% | -21.50% | -42.07% | +693.64% | +70.98% | +107.09% | 10.95B | |
| -7.46% | -6.18% | -10.36% | -6.08% | +13.46% | +104.05% | +104.68% | +120.73% | +496.28% | 10.02B | |
| -0.01% | +0.18% | +1.45% | +138.65% | +82.26% | +173.77% | +413.56% | +269.67% | - | 9B | |
| -2.16% | -4.45% | +6.92% | +16.41% | +29.68% | +94.33% | +14.56% | +125.79% | - | 8.9B | |
| -4.17% | +3.34% | +8.05% | +7.05% | +306.57% | +244.02% | +387.88% | -29.26% | - | 8.53B | |
| -2.63% | +10.04% | -0.12% | +4.15% | +13.40% | -19.40% | +123.09% | -18.76% | - | 8.51B | |
| -3.48% | -15.15% | -10.98% | +22.94% | +175.82% | +447.97% | +536.34% | -49.31% | -37.58% | 7.97B | |
| Average | -2.98% | -1.13% | +8.35% | +20.26% | +49.77% | +84.10% | +223.28% | +192.82% | +1,377.61% | 19.07B | |
| Weighted average by Cap. | -2.74% | -1.16% | +15.18% | +28.43% | +49.30% | +68.67% | +184.21% | +206.93% | +2,758.59% |
- Stock Market
- Stocks
- VAL Stock
- Sector ValiRx plc
Select your edition
All financial news and data tailored to specific country editions
